ESMO 2023 | Positive biomarkers to select patients for bladder preservation in bladder cancer

Andrea Necchi, MD, IRCCS San Raffaele Hospital and Scientific Institute, Milan, Italy, discusses how clinicians can select patients with bladder cancer to avoid cystectomy by assessing key molecular biomarkers. Dr Necchi elaborates on the specific biomarkers for patients who may be eligible for cystectomy avoidance. This interview took place at the European Society for Medical Oncology (ESMO) 2023 Congress in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.